Clint A. Stalnecker

机构：University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center · ORCID：0000-0002-0570-4416

发表论文 250 篇 · 总被引 4876 次 · h-index 18

代表论文

• Abstract 7100: VS-7375: An oral, selective KRAS G12D dual ON/OFF inhibitor with potent anti-tumor activity as a single agent and in combination with other agents (2026 · Cancer Research · 被引 2)
• Characterization and therapeutic suppression of KEAP1-NRF2-driven resistance to KRAS inhibitors in pancreatic and lung cancer (2026 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)
• Abstract LB197: VS-7375, a non-covalent dual ON/OFF KRASG12D inhibitor, displays superior activity to ON-only KRASG12D inhibitors in preclinical models of pancreatic cancer (2026 · Cancer Research · 被引 1)
• Abstract PR007: Anti-tumor efficacy of the selective oral KRAS G12D dual ON/OFF inhibitor VS-7375 as a single agent and in combination with targeted agents (2026 · Cancer Research · 被引 1)
• Concurrent AXL Inhibition Enhances RAS and ERK Inhibitor Efficacy in KRAS -mutant Pancreatic and Lung Cancer (2026 · bioRxiv (Cold Spring Harbor Laboratory))
• Figure 1 from Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling (2026)